FDA Updates Saquinavir Labeling

“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir." “Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.” The updated labeling will be available at the FDA website. More information is available: FDA: Press release AIDSinfo: Patient fact sheet on saquinavir